75N93022F00002↗
Sri International received this contract from National Institutes of Health Niaid, National Institutes of Health: $3.43M obligated so far for health r&d services; health care services; applied research. It runs to 2027-09-29.
Key facts · data as of Oct 26, 2026
- Recipient
- Sri International
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $3.43M
- Potential value
- $12.09M
- Ends
- 2027-09-29
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75N93022F00002, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75N93022F00002_7529_75N93020D00011_7529
Sri International: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
Up for re-bid: ends 2027-09-29. Recompete brief → · 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases ↗
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under 75N93020D00011
- Where the work is
- San Mateo, CA · district CA-16
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
3 subawards totaling $6.70M (195.2% of what was obligated), as Sri International reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Lovelace Biomedical Research Institute | $6.35M | 2 | NM | 2024-06-26 | 2026-03-02 |
| The Medical College of Wisconsin, Inc. | $354.1K | 1 | WI | 2023-02-08 | 2023-02-08 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2024-06-26 | Lovelace Biomedical Research Institute | $4.32M | A 180-DAY MODEL ESTABLISHMENT STUDY FOLLOWING PARTIAL BODY IRRADIATION WITH SUPPORTIVE CARE IN CYNOMOLGUS MONKEYS |
| 2026-03-02 | Lovelace Biomedical Research Institute | $2.02M | CONDUCT A MODEL ESTABLISHMENT STUDY FOLLOWING PARTIAL BODY IRRADIATION WITH G-CSF AND SUPPORTIVE CARE IN RHESUS MONKEYS. PURPOSE OF STUDY IS TO UNDERSTAND THE DOSE RESPONSE RELATIONSHIP (DRR) OF RHESUS NON-HUMAN… |
| 2023-02-08 | The Medical College of Wisconsin, Inc. | $354.1K | PERFORM A NON-GLP EFFICACY LUNG-DEARE STUDY IN WAG/RIJCMCR RATS TO COMPARE RESEARCH GRADE AND APPROVED DRUG PRODUCT FOR A MEDICAL COUNTERMEASURE. THE PRIMARY ENDPOINT WILL BE SURVIVAL AND SECONDARY ENDPOINTS WILL… |
Every action
2 actions since 2023-08-28. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-03-18 | P00002 | Administrative change | $0 | ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING |
| 2023-08-28 | P00001 | Change order | $3.43M | ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗